Shares of Gilead Sciences, Inc. (NASDAQ:GILD) presently have a consensus target price of $100.785. The analyst with the top target price based on data provided by Zacks Research, is presently $118. The analyst with the lowest target estimate on the stock sees shares touching $88. Target price projections may differ from analyst to analyst.
Covering analysts might employ resistance and support levels to assist in evaluating where the stock may be headed in the future. Zacks research also provides recommendations from street analysts that cover the stock. These recommendations fall on a simple scale provided by Zacks Research. Using information provided from various polled analysts, Zacks Research reports shares of Gilead Sciences, Inc. with a current ABR of 1.81. This number is based on a recommendation scale where the ratings range from a 1 to a 5. Following this scale, a 1 would indicate a Strong Buy while a 5 would indicate a Strong Sell.
We can also take a look at some company earnings per share or EPS information. Earnings per share is the segment of profit for a company that is allocated to every outstanding share of a company’s common stock. Earnings per share numbers can serve as an indicator for the profitability of a certain company. EPS is widely considered to be one of the most important factors when evaluating the price of a share. A Zacks consensus currently shows Street analysts projecting the company to post per share earnings of $2.52. For the period ending 2016-09-30, Gilead Sciences, Inc. reported actual EPS of $2.7. This number was $-0.04 away from analyst predictions, providing a surprise factor of -1.46%. The company is expected to next release earnings on or around 2017-02-07.